Target intelligence / Profile preview

Poly-L-arginine (P-Arg)

Target
P-Arg
Molecular classification
Other (Synthetic cationic polypeptide), Biopolymer, Cell-penetrating peptide
01

Overview

Poly-L-arginine is a synthetic, cationic polypeptide comprised exclusively of L-arginine amino acids linked together by peptide bonds. It is not a naturally occurring protein or receptor, but a laboratory-produced polymer notable for its high positive charge. This property enables strong electrostatic interactions with negatively charged molecules and cellular surfaces. Poly-L-arginine is often used in research as a mimic for cell-penetrating peptides (CPPs), in gene/drug delivery applications, and as a model for studying polyelectrolyte behavior. In aqueous solution, it generally adopts a random coil or extended conformation under physiological pH, but can adopt α-helical structures at high pH. Poly-L-arginine's cationic nature can promote membrane translocation of attached cargo, but also introduces cytotoxicity at elevated concentrations by destabilizing cellular membranes. It is not itself a receptor, enzyme, or classical biological drug target, but is important as an experimental reagent in both biomedical and material science contexts.

Other names
Poly(L-arginine)P-ArgPoly-L-Arginine hydrochloridepolyarginine
02

Mechanism of action

When used as a cell-penetrating peptide: enables cargo (e.g., nucleic acids, proteins, nanoparticles) to enter cells by destabilizing membranes and facilitating translocation. Acts through strong electrostatic interaction with negatively charged cell components, such as glycosaminoglycans in the extracellular matrix or plasma membrane.

03

Biological functions

Facilitates macromolecule and drug delivery across cell membranes (as a cell-penetrating peptide or CPP in experimental settings)Used as a model polyelectrolyte in biophysical/physicochemical studiesCan serve as a supporting layer for nanoparticle/protein immobilization in material sciences
04

Disease associations

Used in research for gene delivery, drug delivery, and antimicrobial peptide studiesNot directly implicated in human disease biology
05

Safety considerations

Notable cytotoxicity at high concentrations due to membrane destabilization effectsPotential for nonspecific cellular uptake, causing off-target effects in vitroInduces cell membrane permeabilization, which may result in cell lysis at high concentrations
06

Interacting drugs

None (Poly-L-arginine is not a canonical drug target; rather, it can be a delivery agent for nucleic acids or drugs in research and biotechnology)
07

Biomarkers

None (no clinically validated biomarkers for its use; it is not a disease-associated target)

Beyond the preview

Go deeper on Poly-L-arginine (P-Arg).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Poly-L-arginine (P-Arg).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call